drugset / Trial / NCT03460158

Prospective Evaluation of Facial Cosmetic Procedures

NCT03460158

Phase 4 Completed 101 enrolled University of Pennsylvania Galderma R&D · collab
NaSingle-groupOpen-labelTreatment

Summary

A prospective, trial to quantitatively and qualitatively compare the dermal fillers for the treatment of age related aesthetic changes.

Timeline

Start
2020-08-21
Primary completion
2024-02-28
Completion
2024-05-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Restylane Silk Other / unclassified Other
Subject Restylane-L® Other / unclassified Other
Subject Restylane-L® Lyft Other / unclassified Other

Indications

No indication recorded.